心房颤动患者经皮冠状动脉介入治疗术后三联抗栓治疗的研究进展被引量：10

Review on triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

原文传递

导出

摘要心房颤动患者中约有三分之一合并有冠心病,当这些患者进行经皮冠状动脉介入治疗(PCI)术后往往需要抗凝药物联合抗血小板的三联抗栓治疗,但是这种治疗方式出血风险较高。本文主要介绍了三联抗栓治疗的最新研究进展,为临床实践提供参考。 A third of patients with atrial fibrillation（AF） complicated coronary heart disease（CHD）,most of them need to take triple antithrombotic therapy after undergoingpercutaneous coronary intervention.However, this treatment has a higher risk of bleeding. This review summarizes the recent researches on triple antithrombotic therapy,and hopes to provide a reference forclinical practice.

作者刘文禹俞晶晶陈传品阳国平 LIU Wen - yu YU Jing - jing CHEN Chuan - pin YANG Guo - ping(Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China Center of Clinical Pharmacology, The Third Xiangya Hospital of Central South University, Changsha 410013, China)

机构地区中南大学湘雅药学院中南大学湘雅三医院临床药理中心

出处《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第12期1161-1164,共4页 The Chinese Journal of Clinical Pharmacology

基金国家国际科技合作专项基金资助项目(2014DFA30900)

关键词三联抗栓治疗心房颤动经皮冠状动脉介入抗凝 triple antithrombotic therapy atrial fibrillation percutaneous coronary intervention anticoagulation

分类号 R973.2 [医药卫生—药品]

引文网络
相关文献

参考文献1

1中国心房颤动患者卒中预防规范[J].中华心律失常学杂志,2015,19(3):162-173. 被引量：80

二级参考文献55

1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1399
2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量：162
3Hu D, Sun Y. Epidemiology, risk factors for stroke, and manage- ment of atrial fibrillation in China [ J ]. J Am Coil Cardiol, 2008, 52:865-868.
4Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin thera- py[ J]. J Am Coil Cardio1,2003,41 : 1633-1652. [ No authors listed].
5Stroke Prevention in Atrial Fibrillation Study. Final Results[ J]. Circulation, 1991,84:527-539.
6Carabello BA. Modem management of mitral stenosis [ J ]. Circula- tion ,2005,112:432-437.
7Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heatrt disease [ J ]. Am J Cardiol, 1996,77:96-98.
8Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries [ J ]. Int J Cardio1,2013 ,167 :2412-2420.
9Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France : The AL- FA study. The College of French Cardilolgists [ J ]. Circulation, 1999,99 : 3028 -3035.
10Krahn AD,Manfreda J,Tate RB,et al. The natural history of atrial fibrillation:incidence, risk factors, and prognosis in the Manitoba Follow-Up Study[ J ]. Am J Med, 1995,98:476-484.